| Application no. and date | 12820058.1 (espacenet) (Federated) (European Patent Register), 20120727 | | Patent/reg. no. and date | DK/EP 2819516, 20191225 | | Publication date | 20150107 | | Priority no. and date | US 201161574231 P, 20110730, US 201113334066, 20111222, US 201213528940, 20120621 | | EP pub. no. and date |
EP 2819516 20150107 | | Effective date | | | Applicant/owner | Otsuka America Pharmaceutical, Inc., 2440 Research Boulevard
Rockville, MD 20850, US | | Applicant ref. no. | P72397DK01 | | Inventor | BYMASTER, Frank, 8545 North County Road 650 East
Brownsburg, IN 46112, US,
MCKINNEY, Anthony Alexander, 38 Braeland Avenue
Suite 2
Newton Center, MA 02459, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/403 (2006.01) , A61K 9/00 (2006.01) , A61P 25/00 (2006.01) | | Title | ANVENDELSE AF (1R,5S)-(+)-1-(NAPHTHALEN-2-YL)-3-AZABICYCLO{3.1.0}HEXAN I BEHANDLINGEN AF LIDELSER FORBUNDET MED MONOAMIN-NEUROTRANSMITTERE | | Int. application no. | US2012000335 | | Int. publication no. | WO2013019271 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
